GSK is investing $800M+ to expand its Upper Merion, PA site into a full biopharma hub.
300+ new jobs coming, construction starts 2027.
Combined with their Lancaster project, nearly $1.7B headed to Pennsylvania.
Solid win for the local life sciences scene.